Multiparametric ultrasound vs. multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.
7 Mar, 2022 | 00:04h | UTCMultiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study – The Lancet Oncology (link to abstract – $ for full-text)
News Release: Ultrasound scan can diagnose prostate cancer – Imperial College London
Commentary on Twitter
In a prospective confirmatory study comparing multiparametric US vs MRI for prostate cancer detection in 306 men with an abnormal PSA or DRE findings, US detected 4.3% fewer clinically significant cancers despite 11.1% more pts being referred for a biopsy: https://t.co/ZFkiUTFJ5Y
— NatureRevClinOncol (@NatRevClinOncol) March 3, 2022